Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: an international multicenter cohort study

BACKGROUND: Adjuvant therapy prolongs survival in patients with pancreatic ductal adenocarcinoma. However, no clear guidelines are available regarding the oncologic effects of adjuvant therapy (AT) in resected invasive intraductal papillary mucinous neoplasms (IPMN). The aim was to investigate the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Munseok, Wang, Shin-E, Park, Joon Seong, Kim, Hyung Sun, Choi, Sung Hoon, Lee, Jin Ho, Chong, Jae Uk, Nagakawa, Yuichi, Wada, Keita, Nakamura, Yoshiharu, Sunagawa, Hiroki, Dasari, Bobby VM, Peng, Cheng-Ming, Seng, Lee Lip, Wolters, Heiner, Gurbadam, Unenbat, Park, Byoung UK, Winslow, Emily, Fishbein, Thomas, Hawksworth, Jason, Radkani, Pejman, Kang, Chang Moo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583921/
https://www.ncbi.nlm.nih.gov/pubmed/37300881
http://dx.doi.org/10.1097/JS9.0000000000000537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583921/
https://www.ncbi.nlm.nih.gov/pubmed/37300881
http://dx.doi.org/10.1097/JS9.0000000000000537

Ejemplares similares